Common Contracts
7 similar Placement Agency Agreement contracts by Aradigm Corp, Adventrx Pharmaceuticals Inc, Electro Optical Sciences Inc /Ny, others
2,400,000 Shares of Common Stock ELECTRO-OPTICAL SCIENCES, INC. PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 17th, 2009 • Electro Optical Sciences Inc /Ny • Surgical & medical instruments & apparatus
4,000,000 Shares Aradigm Corporation Common Stock (No Par Value) PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 26th, 2009 • Aradigm Corp • Electromedical & electrotherapeutic apparatus • New York
Aradigm Corporation, a California corporation (the “Company”), proposes, subject to the terms and conditions stated in this Placement Agency Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the investors identified therein (each, an “Investor” and collectively, the “Investors”), to issue and sell an aggregate of 4,000,000 shares (the “Shares”) of the Company’s common stock, no par value per share (the “Common Stock”). The Shares are more fully described in the Registration Statement (as defined herein). This is to confirm the agreement between the Company and the several placement agents set forth on Schedule I attached hereto (the “Placement Agents”) concerning the offering, issuance and sale of the Shares. Piper Jaffray & Co. is acting as representative (the “Representative”) of the Placement Agents.
40,663,071 Shares Aradigm Corporation Common Stock (No Par Value) PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 24th, 2009 • Aradigm Corp • Electromedical & electrotherapeutic apparatus • New York
Aradigm Corporation, a California corporation (the “Company”), proposes, subject to the terms and conditions stated in this Placement Agency Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the investors identified therein (each, an “Investor” and collectively, the “Investors”), to issue and sell an aggregate of 40,663,071 shares (the “Shares”) of the Company’s common stock, no par value per share (the “Common Stock”). The Shares are more fully described in the Registration Statement (as defined herein). This is to confirm the agreement between the Company and the several placement agents set forth on Schedule I attached hereto (the “Placement Agents”) concerning the offering, issuance and sale of the Shares. Piper Jaffray & Co. is acting as representative (the “Representative”) of the Placement Agents.
SHARES MICROVISION, INC. COMMON STOCK PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 18th, 2008 • Microvision Inc • Electronic components, nec • New York
Microvision, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this Placement Agency Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the investors identified therein (each, an “Investor” and collectively, the “Investors”), to issue and sell an aggregate of shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The Shares are more fully described in the Registration Statement (as defined herein). This is to confirm the agreement between the Company and the several placement agents set forth on Schedule I attached hereto (the “Placement Agents”) concerning the offering, issuance and sale of the Shares. FTN Midwest Securities Corp is acting as representative (the “Representative”) of the Placement Agents.
10,727,500 Shares ENTREMED, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 13th, 2006 • Entremed Inc • Biological products, (no disgnostic substances) • New York
EntreMed, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell up to an aggregate of 10,727,500 shares (the “Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”) to certain investors (each an “Investor” and, collectively, the “Investors”). The Company desires to engage ThinkEquity Partners LLC (“ThinkEquity”) as lead placement agent, and Rodman & Renshaw, LLC (“Rodman” and together with ThinkEquity, the “Placement Agents”) as co-placement agent, as set forth herein in connection with such issuance and sale. ThinkEquity is acting as representative of the Placement Agents (the “Representative”). The Shares are more fully described in the Registration Statement (as hereinafter defined).
14,545,000 Shares ADVENTRX PHARMACEUTICALS, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 3rd, 2006 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell up to an aggregate of 14,545,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) to certain investors (each an “Investor” and, collectively, the “Investors”). The Company desires to engage ThinkEquity Partners LLC (“ThinkEquity”) and Fortis Securities LLC (“Fortis” and together with ThinkEquity, the “Placement Agents”) as its exclusive placement agents as set forth herein in connection with such issuance and sale. ThinkEquity is acting as representative of the Placement Agents (the “Representative”). The Shares are more fully described in the Registration Statement (as hereinafter defined).
3,040,000 Shares EMISPHERE TECHNOLOGIES, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 11th, 2006 • Emisphere Technologies Inc • Pharmaceutical preparations • New York
Emisphere Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to certain investors (each an “Investor” and, collectively, the “Investors”), up to an aggregate of 3,040,000 shares (the “Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”). The Company desires to engage ThinkEquity Partners LLC (“ThinkEquity”), W.R. Hambrecht + Co., LLC (“W.R. Hambrecht”) and WBB Securities, LLC (“WBB Securities”, and together with ThinkEquity and W.R. Hambrecht, the “Placement Agents”) as its exclusive placement agents (the “Placement Agents”) in connection with such issuance and sale of the Shares. ThinkEquity is acting as representative of the Placement Agents (the “Representative”).
